UP!
| 2016-07-06 | Initiated Coverage | Maxim Group | Buy | $12.00 |
| 2016-06-06 | Reiterated Rating | Maxim Group | Buy | |
| 2016-05-12 | Reiterated Rating | Piper Jaffray | Hold | $8.00 to $5.00 |
| 2016-05-12 | Reiterated Rating | Leerink Swann | Hold | |
| 2016-05-12 | Reiterated Rating | Piper Jaffray Cos. | Hold | $8.00 to $5.00 |
| 2016-05-11 | Reiterated Rating | Cantor Fitzgerald | Hold | $5.00 |
| 2016-04-28 | Downgrade | Argus | Buy to Hold | |
| 2016-04-26 | Downgrade | Leerink Swann | Outperform to Sector Perform | |
| 2016-04-25 | Downgrade | Piper Jaffray | Overweight to Neutral | $5.26 to $8.00 |
| 2016-04-25 | Downgrade | Cantor Fitzgerald | Buy to Hold | $9.00 to $5.00 |
| 2016-04-25 | Downgrade | Leerink Partner | Outperform to Market Perform | |
| 2016-03-29 | Reiterated Rating | Avondale Partners | Market Perform | $6.00 |
| 2016-03-28 | Reiterated Rating | Cantor Fitzgerald | Buy | $10.00 |
| 2016-03-12 | Reiterated Rating | Piper Jaffray | Overweight | $8.00 |
| 2016-03-12 | Reiterated Rating | Maxim Group | Buy | |
| 2016-03-11 | Downgrade | Janney Montgomery Scott | Buy to Neutral | |
| 2016-03-11 | Reiterated Rating | Cantor Fitzgerald | Buy | $10.00 |
| 2016-03-01 | Reiterated Rating | Maxim Group | Buy | $12.00 |
| 2016-02-22 | Reiterated Rating | Jefferies Group | Buy | |
| 2016-02-03 | Reiterated Rating | Maxim Group | Buy | $13.00 to $12.00 |
| 2016-01-31 | Reiterated Rating | Cantor Fitzgerald | Buy | $10.00 |
| 2016-01-25 | Reiterated Rating | Cantor Fitzgerald | Buy | $10.00 |
| 2016-01-06 | Initiated Coverage | Avondale Partners | Market Perform | $6.00 |
| 2015-11-10 | Lower Price Target | Leerink Swann | Outperform | $9.00 to $8.00 |
| 2015-10-27 | Reiterated Rating | Maxim Group | Buy | $13.00 |
| 2015-09-22 | Reiterated Rating | Maxim Group | Buy | $13.00 |
| 2015-09-15 | Initiated Coverage | Cantor Fitzgerald | Buy | $10.00 |
| 2015-08-14 | Initiated Coverage | Leerink Swann | Outperform | $9.00 |
| 2015-07-10 | Reiterated Rating | Maxim Group | Buy | |
| 2015-07-03 | Reiterated Rating | Cantor Fitzgerald | Buy | $14.00 |
| 2015-07-02 | Reiterated Rating | Maxim Group | Buy | |
| 2015-06-23 | Initiated Coverage | Maxim Group | Buy | |
| 2015-05-09 | Reiterated Rating | Piper Jaffray | Overweight | $7.00 to $9.00 |
| 2015-04-20 | Boost Price Target | Maxim Group | Buy | $10.00 to $13.00 |
| 2015-04-02 | Initiated Coverage | Janney Montgomery Scott | Fair Value to Buy | $6.75 to $11.00 |
| 2015-03-27 | Reiterated Rating | Cantor Fitzgerald | Buy | $8.00 |
| 2015-03-13 | Boost Price Target | Piper Jaffray | $7.00 | |
| 2015-02-17 | Initiated Coverage | Piper Jaffray | Overweight | $6.25 |
| 2014-07-10 | Initiated | Maxim Group | Buy | $10 |
| 2014-07-09 | Initiated Coverage | Maxim Group | Buy | $10.00 |
| 2013-11-15 | Reiterated Rating | Aegis | In-Line | |
| 2013-11-13 | Lower Price Target | Aegis | Buy | $14.00 to $10.00 |
| 2013-10-01 | Reiterated Rating | Aegis | Buy | $14.00 |
| 2013-07-16 | Initiated | Cantor Fitzgerald | Buy | $10 |
| 2013-04-01 | Reiterated | Aegis Capital | Buy | $12 to $14 |
| 2016-07-06 | Initiated Coverage | Maxim Group | Buy | $12.00 |
| 2016-06-06 | Reiterated Rating | Maxim Group | Buy | |
| 2016-05-12 | Reiterated Rating | Piper Jaffray | Hold | $8.00 to $5.00 |
| 2016-05-12 | Reiterated Rating | Leerink Swann | Hold | |
| 2016-05-12 | Reiterated Rating | Piper Jaffray Cos. | Hold | $8.00 to $5.00 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In TROV 8 funds of 2213 total. Show all
| Fund name | Ticker shares |
|---|---|
| BlackRock Fund Advisors | 0.90M |
| BlackRock Institutional Trust Company, N.A. | 0.66M |
| BlackRock Investment Management, LLC | 0.11M |
| WINDSOR FINANCIAL GROUP LLC | 62500 |
| PRINCETON CAPITAL MANAGEMENT INC | 17070 |
| BLACKROCK ADVISORS LLC | 14553 |
| KCG Holdings, Inc. | 10986 |
| LBA Wealth Management, LLC | 2000 |
| Name Relationship | Total Shares | Holding stocks |
|---|---|---|
| Hunter Robert Merrill | 26.80% (5065004) | SGYP / TROV / |
| BRIDGER MANAGEMENT, LLC | 17.41% (3290587) | PFSI / RGDX / TROV / |
| Sheinerman Kira | 4.81% (909090) | TROV / |
| WELCH WILLIAM J CEO | 4.46% (842645) | SQNM / TROV / |
| CERRONE GABRIEL | 3.81% (719526) | SGYP / TROV / |
| ADAMS THOMAS PHD | 1.86% (351959) | LJPC / SGYP / TROV / |
| Tennant Stanley | 1.20% (226061) | BKOR / TROV / |
| JACOB GARY S | 0.79% (148954) | SGYP / TROV / |
| Erlander Mark Chief Scientific Officer | 0.55% (104367) | TROV / |
| ZANIBONI STEVE CFO | 0.51% (96968) | SRNE / TROV / |
| BRANCACCIO JOHN P | 0.23% (43167) | SGYP / TROV / |
| Billings Paul | 0.12% (23165) | CLRX / TROV / |
| Markin Rodney S | 0.12% (22610) | TBIO / TROV / |
| SCHUH ANTONIUS CEO | 0.11% (20000) | SRNE / TBIO / TROV / |
UM